Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Type

Guidance programme 1 selected

Guidance programme

Showing 11 to 18 of 18

TitleReference numberPublishedLast updated
Trifluridine–tipiracil for previously treated metastatic colorectal cancerTA405
Regorafenib for metastatic colorectal cancer after treatment for metastatic disease (terminated appraisal)TA334
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapyTA307
Cetuximab, bevacizumab and panitumumab for the treatment of metastatic colorectal cancer after first-line chemotherapyTA242
Bevacizumab and cetuximab for the treatment of metastatic colorectal cancerTA118
Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancerTA212
Laparoscopic surgery for colorectal cancerTA105
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancerTA61

Results per page

  1. 10
  2. 25
  3. 50
  4. All